Louise Emmett
Tracked across 1 events · 6 articles · First seen Apr 27, 2026 · Last active Apr 28, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Professor Louise Emmett will discuss effective PSMA-targeted therapy and present data from her OPTIMAL-PSMA trial of TLX597-Tx, a Telix Pharmaceuticals candidate, which could influence the perception of Telix Pharmaceuticals' product.
Apr 27, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Louise Emmett live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard